Catamaran Corp (USA)  

(Public, NASDAQ:CTRX)   Watch this stock  
Find more results for NASDAQ:SXCI
60.22
+0.15 (0.25%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 60.06 - 60.24
52 week 39.40 - 60.44
Open 60.11
Vol / Avg. 1.26M/3.04M
Mkt cap 12.48B
P/E 36.80
Div/yield     -
EPS 1.64
Shares 207.49M
Beta -0.17
Inst. own 85%
Jul 30, 2015
Q2 2015 Catamaran Corp Earnings Release (Estimated) - 6:00AM EDT - Add to calendar
May 13, 2015
Catamaran Corp Annual Shareholders Meeting (Estimated)
May 12, 2015
Catamaran Corp Annual Shareholders Meeting - Webcast
Apr 30, 2015
Q1 2015 Catamaran Corp Earnings Release
Mar 10, 2015
Catamaran Corp at Barclays Healthcare Conference
Mar 2, 2015
Catamaran Corp at Cowen Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 1.66% 1.73%
Operating margin 2.66% 2.64%
EBITD margin - 3.92%
Return on average assets 4.25% 4.32%
Return on average equity 6.54% 6.23%
Employees 4,500 -
CDP Score - -

Address

1600 McConnor Pkwy
SCHAUMBURG, IL 60173-6801
United States - Map
+1-800-2823232 (Phone)
+1-224-2311901 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Catamaran Corporation (Catamaran), formerly SXC Health Solutions Corp. is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company’s PBM services are marketed under the Catamaran PBM brand, includes electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, and reporting and information analysis. Its HCIT solutions include: RxCLAIM, an on-line transaction processing system that provides instant adjudication of prescription drug claims; RxMAX, rebate management system; RxTRACK, data warehouse and analysis system, and Zynchros, formulary management tools. Its customers include organizations in the pharmaceutical supply chain.

Officers and directors

Mark A. Thierer Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Michael Shapiro Chief Financial Officer, Senior Vice President
Age: 44
Bio & Compensation  - Reuters
Jeffrey Park Executive Vice President - Operations
Age: 43
Bio & Compensation  - Reuters
John Romza Executive Vice President - Quality and Innovation
Age: 59
Bio & Compensation  - Reuters
Joel Saban Executive Vice President - Pharmacy Operations
Age: 47
Bio & Compensation  - Reuters
Clifford E. Berman Senior Vice President, General Counsel, Corporate Secretary
Age: 55
Bio & Compensation  - Reuters
Steven D. Cosler Lead Independent Director
Age: 59
Bio & Compensation  - Reuters
Peter J. Bensen Independent Director
Age: 52
Bio & Compensation  - Reuters
William J. Davis Independent Director
Age: 47
Bio & Compensation  - Reuters
Steven B. Epstein J.D. Independent Director
Age: 71
Bio & Compensation  - Reuters